Transcriptomic and Proteomic Profiling of Circulating Tumor Cells to Identify Predictive Biomarkers of Chemotherapeutic Response in Triple-Negative Breast Cancer. ICMERD-IJMS [Internet]. 2022 Jan. 17 [cited 2026 Jan. 29];3(1):1-7. Available from: https://icmerd.org/index.php/ICMERD-IJMS/article/view/ICMERD-IJMS_03_01_001